Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: A double-blinded, randomized, placebo-controlled crossover trial

Clinical and Experimental Hypertension

Volumn 35, Issue 5, 2013, Pages 313-324

  Matthesen, Solveig K ^a   Larsen, Thomas ^a   Vase, Henrik ^a   Lauridsen, Thomas G ^a   Jensen, Janni M ^a   Pedersen, Erling B ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Aldosterone; Amiloride; Angiotensin; Aquaporin 2; Clinical trial; ENaC; Hypertension; Potassium; Renin; Sodium; Spironolactone; Vasopressin; Water

Indexed keywords

ALDOSTERONE; AMILORIDE; ANGIOTENSIN II; AQUAPORIN 2; EPITHELIAL SODIUM CHANNEL; FUROSEMIDE; PLACEBO; POTASSIUM; RENIN; SPIRONOLACTONE;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MONITORING; BOLUS INJECTION; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FLUID INTAKE; FREE WATER CLEARANCE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY TUBULE FUNCTION; LOW CALORY DIET; MALE; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SODIUM ABSORPTION; SODIUM EXCRETION; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; URINARY EXCRETION; WATER ABSORPTION;

EID: 84884996129     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2012.721843     Document Type: Article

References (48)

1. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003; 42:1093-1099.
2. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. 1988.
3. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002; 16:761-770.
4. Adrogue HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 2007; 356:1966-1978.
5. Sacks FM, Svetkey LP, Vollmer WM et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3-10.
6. Whelton PK. Effects of oral potassium on blood pressure. Metaanalysis of randomized controlled clinical trials. J Am Med Assoc 1997; 277(20):1624-1632.
7. Matthesen SK, Larsen T, Vase H, Lauridsen TG, Pedersen EB. Effect of potassium supplementation on renal tubular function, ambulatory blood pressure and pulse wave velocity in healthy humans. Scand J Clin Lab Invest 2012; 72(1):78-86 [Epub 2011 Dec 12].
8. Matthesen SK, Larsen T, Lauridsen TG et al. Effect of amiloride and spironolactone on renal tubular function, ambulatory blood pressure, and pulse wave velocity in healthy participants in a double-blinded, randomized, placebo-controlled, crossover trial. Clin Exp Hypertens 2012 [Epub ahead of print].
9. Shimkets RA, Warnock DG, BositisCMet al. Liddle's syndrome heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79(3):407-414.
10. Kemendy AE, Kleyman TR, Eaton DC. Aldosterone alters the open probability of amiloride-blockable sodium channels in A6 epithelia. Am J Physiol 1992; 263:C825-C837.
11. Pacha J, Frindt G, Antonian L, Silver RB, Palmer LG. Regulation of Na channels of the rat cortical collecting tubule by aldosterone. J Gen Physiol 1993; 102:25-42.
12. Fuller PJ, Young MJ. Mechanisms of mineralocorticoid action. Hypertension 2005; 46:1227-1235.
13. Funder JW. Mineralocorticoid receptors: distribution and activation. Heart Fail Rev 2005; 10(1):15-22.
14. Canessa CM, Schild L, Buell G et al. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 1994; 367(6462):463-467.
15. Renard S, Lingueglia E, Voilley N, Lazdunski M, Barbry P. Biochemical analysis of the membrane topology of the amiloridesensitive Na+ channel. J Biol Chem 1994; 269:12981-12986.
16. Lauridsen TG, Vase H, Bech JN, Nielsen S, Pedersen EB. Direct effect of methylprednisolone on renal sodium and water transport via the principal cells in the kidney. Eur J Endocrinol 2010; 162:961-969.
17. Lauridsen TG, Vase H, Starklint J, Bech JN, Pedersen EB. Protein enriched diet increases water absorption via the aquaporin2 water channels in healthy humans. Nephrol Dial Transplant 2010; 25:2502-2510.
18. Graffe CC, Bech JN, Pedersen EB. The effect of high and low sodium intake on urinary aquaporin-2 excretion in healthy humans. Am J Physiol Renal Physiol 2012; 302:F264-F275.
19. Graffe CC, Bech JN, Lauridsen TG, Vase H, Pedersen EB. Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension. BMC Nephrol 2012; 13:15 [Epub ahead of print].
20. Graffe CC, Bech JN, Lauridsen TG, Pedersen EB. Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion. Am J Physiol Renal Physiol 2012; 302(8):F917-F927 [Epub ahead of print].
21. Deen PM, Croes H, van Aubel RA, Ginsel LA, van Os CH. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest 1995; 95:2291-2296.
22. Sabolic I, Katsura T, Verbavatz JM, Brown D. The AQP2 water channel: effect of vasopressin treatment, microtubule disruption, and distribution in neonatal rats. JMembr Biol 1995; 143:165-175.
23. Marples D, Knepper MA, Christensen EI, Nielsen S. Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct.AmJ Physiol 1995; 269:C655-C664.
24. Nielsen S, Chou CL, Marples D, Christensen EI, Kishore BK, Knepper MA. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci USA 1995; 92:1013-1017.
25. Yamamoto T, Sasaki S, Fushimi K et al. Vasopressin increases AQP-CD water channel in apical membrane of collecting duct cells in Brattleboro rats. Am J Physiol 1995; 268:C1546-C1551.
26. Kanno K, Sasaki S, HirataY et al. Urinary excretion of aquaporin- 2 in patients with diabetes insipidus. N Engl J Med 1995; 332 (23):1540-1545.
27. Rai T, Sekine K, Kanno K et al. Urinary excretion of aquaporin-2 water channel protein in human and rat. J Am Soc Nephrol 1997; 8(9):1357-1362.
28. Wen H, Frokiaer J, Kwon TH, Nielsen S. Urinary excretion of aquaporin-2 in rat is mediated by a vasopressin-dependent apical pathway. J Am Soc Nephrol 1999; 10:1416-1429.
29. Pedersen RS, Bentzen H, Bech JN, Pedersen EB. Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol Renal Physiol 2001; 280(5):F860-F867.
30. Buemi M, Nostro L, Di Pasquale G et al. Aquaporin-2 water channels in spontaneously hypertensive rats. Am J Hypertens 2004; 17:1170-1178.
31. Energy and protein requirements. Report of a joint FAO/WHO/ UNU expert consultation. World Health Organ Tech Rep Ser 1985; 724:1-206.
32. Hager H, Kwon TH, Vinnikova AK et al. Immunocytochemical and immunoelectron microscopic localization of alpha-, beta-, and gamma-ENaC in rat kidney. Am J Physiol Renal Physiol 2001; 280(6):F1093-F1106.
33. Garty H, Palmer LG. Epithelial sodium channels: function, structure, and regulation. Physiol Rev 1997; 77(2):359-396.[Review].
34. Schluter T, Rohsius R, Wanka H et al. Amiloride lowers arterial pressure in cyp1a1ren-2 transgenic rats without affecting renal vascular function. J Hypertens 2010; 28(11):2267-2277.
35. Wang X,TakeyaK, Aaronson PI, LoutzenhiserK, Loutzenhiser R. Effects of amiloride, benzamil, and alterations in extracellular Na+ on the rat afferent arteriole and itsmyogenic response.AmJ Physiol Renal Physiol 2008; 295(1):F272-F282 [Epub 2008 May 21].
36. Drummond HA, Grifoni SC, Jernigan NL. A new trick for an old dogma: ENaC proteins as mechanotransducers in vascular smooth muscle. Physiology (Bethesda) 2008; 23:23-31.
37. Jansen PM, Danser AH, Imholz BP, van den Meiracker AH. Aldosterone-receptor antagonism in hypertension. J Hypertens 2009; 27(4):680-691.
38. Marrs JC. Spironolactone management of resistant hypertension. Ann. Pharmacother 2010; 44(11):1762-1769.
39. Schupp N, Kolkhof P, Queisser N et al. Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats. FASEB J 2011; 25(3):968-978 [Epub 2010 Dec 6].
40. Susic D, Varagic J, Frohlich ED. Cardiovascular effects of inhibition of renin-angiotensin aldosterone system components in hypertensive rats given salt excess. Am J Physiol Heart Circ Physiol 2010; 298(4):H1177-H1181 [Epub 2010 Jan 29].
41. Batterink J, Stabler SN, Tejani AM, Fowkes CT. Spironolactone for hypertension. Cochrane Database Syst Rev 2010; 4(8 CD008169.
42. Onofriescu M, Mardare NG, Segall L et al. Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: effects on blood pressure, hydration status, and arterial stiffness. Int Urol Nephrol 2012; 44 (2):583-591 [Epub 2011 Jun 19].
43. Laurent S, Cockcroft J, Van Bortel L et al. European network for non-invasive investigation of large arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27(21):2588-2605 [Epub 2006 Sep 25].
44. Sonalker PA, Tofovic SP, Bastacky SI, Jackson EK. Chronic noradrenaline increases renal expression of NHE-3, NBC-1, BSC-1 and aquaporin-2. Clin Exp Pharmacol Physiol 2008; 35 (5-6):594-560.
45. de Seigneux S, Nielsen J, Olesen ET et al. Long-term aldosterone treatment induces decreased apical but increased basolateral expression of AQP2 in CCD of rat kidney. Am J Physiol Renal Physiol 2007; 293(1):F87-F99 [Epub 2007 Mar 20].
46. Kwon TH, Nielsen J, Knepper MA, Frokiaer J, Nielsen S. Angiotensin II AT1 receptor blockade decreases vasopressininduced water reabsorption and AQP2 levels in NaCl-restricted rats. Am J Physiol Renal Physiol 2005; 288(4):F673-F684.
47. Lee YJ, Song IK, Jang KJ et al. Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor. Am J Physiol Renal Physiol 2007; 292(1):F340-F350.
48. Wong NL, Tsui JK. Angiotensin II upregulates the expression of vasopressin V2 mRNA in the inner medullary collecting duct of the rat. Metabolism 2003; 52(3):290-295.